and/or
529 News Items found
Feature
Group photo of researchers Michael Berger, Marc Ladanyi, Dana Tsui, Rose Brannon, Ryma Benayed, Ahmet Zehir, and David Klimstra.
How MSK-ACCESS Blood Test for Cancer was Created
MSK-ACCESS, a blood test that can detect mutations in 129 genes related to cancer, has already helped guide the treatment of more than 2,800 patients at MSK.
In the Lab
Physician-scientist Omar Abdel-Wahab
Research Suggests How Boosting Neoantigens Can Make Immunotherapy More Effective
In mice, drugs that change the way proteins are assembled appear to make checkpoint inhibitor drugs work better.
MSK computational biologist Sohrab Shah
Scientists Obtain Real-Time Look at How Cancers Evolve
With the help of machine learning, computational biologists are learning to predict how cancers will evolve.
Finding
Zsofia Stadler
Knowledge of Inherited Gene Mutations Increasingly Can Guide Cancer Treatment
An analysis of patients who received molecular testing at MSK has found that about half of those with hereditary gene mutations could benefit from treatment with therapies that target those alterations.
SKI immunologist Michael Glickman
MSK Scientists Solve One of TB’s Deadliest Tricks
Scientists at Memorial Sloan Kettering have pieced together the biochemical mechanism by which the tuberculosis bacterium sneaks past our immune defenses.
In the Lab
Developmental biologist Luis Parada
Stem Cells May Explain Why Rare Inherited Tumor in Kids Is So Aggressive
Sloan Kettering Institute investigators have found that a subpopulation of cells within a type of sarcoma called malignant peripheral nerve sheath tumor appear to be similar to a type of neural stem cells.
In the Lab
Structural biologist Stephen Long in his lab
High-Tech Microscope Reveals Inner Workings of Protein Assembly Machinery
Sloan Kettering Institute investigators have learned how Hedgehog proteins, which are important in both development and cancer, are assembled.
Five MSK researcher headshots
ASCO 2021 Research Roundup: Focus on Immunotherapy
Read about the latest findings in immunotherapy from the 2021 annual meeting of the American Society of Clinical Oncology (ASCO).
Sloan Kettering Institute immunologists Joseph Sun and Sam Sheppard
SKI Scientists Learn What Fuels the ‘Natural Killers’ of the Immune System
Sloan Kettering Institute scientists are understanding more about natural killer (NK) cells, which are your allies when it comes to fighting infections and cancer.
In the Lab
Illustration of a fish inside a bubble-like structure. The fish has strands of genetic material coming from its mouth. Outside the bubble is a worm-like creature with an open mouth, ready to gobble up the fish.
Researchers Discover New Cancer Cell Vulnerability: Droplets in the Nucleus
SKI researchers have learned how tiny droplets prevent a cancer-causing type of messenger RNA from being degraded in leukemia cells.